BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 88509)

  • 41. Segmental demyelinating disease: reliability of nerve conduction measurements.
    Kim S
    Arch Phys Med Rehabil; 1980 May; 61(5):210-3. PubMed ID: 7377940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Guillain-Barré syndrome or "new" Chinese paralytic syndrome in northern China?
    Tang XF; Zhang XJ
    Electroencephalogr Clin Neurophysiol; 1996 Apr; 101(2):105-9. PubMed ID: 8647015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pattern of sensory conduction in Guillain-Barre Syndrome.
    Bansal R; Kalita J; Misra UK
    Electromyogr Clin Neurophysiol; 2001; 41(7):433-7. PubMed ID: 11721299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Subclinical lesions of peripheral nervous system in multiple sclerosis patients].
    Pogorzelski R; Baniukiewicz E; Drozdowski W
    Neurol Neurochir Pol; 2004; 38(4):257-64. PubMed ID: 15383952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electrophysiological findings in hereditary motor and sensory neuropathy type I and II--a conduction velocity study.
    Emeryk-Szajewska B; Badurska B; Kostera-Pruszczyk A
    Electromyogr Clin Neurophysiol; 1998 Mar; 38(2):95-101. PubMed ID: 9553747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hereditary motor sensory neuropathies in childhood.
    Rossi LN; Lütschg J; Meier C; Vassella F
    Dev Med Child Neurol; 1983 Feb; 25(1):19-31. PubMed ID: 6832495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nerve biopsy in children with severe Guillain-Barré syndrome and inexcitable motor nerves.
    Massaro ME; Rodriguez EC; Pociecha J; Arroyo HA; Sacolitti M; Taratuto AL; Fejerman N; Reisin RC
    Neurology; 1998 Aug; 51(2):394-8. PubMed ID: 9710009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Guillain-Barré syndrome: clinical and electroneuromyographic studies.
    Takeuchi H; Takahashi M; Kang J; Ueno S; Yamada A; Miki H; Tarui S
    J Neurol; 1984; 231(1):6-10. PubMed ID: 6716113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patterns and severity of conduction abnormalities in Guillain-Barré syndrome.
    Brown WF; Snow R
    J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):768-74. PubMed ID: 1659615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The Guillain-Barré syndrome. The clinico-electrophysiological correlations].
    Carlizzi MN; Lamba LD; Ravera G; Veneselli E; Bartoli D; Cottafava F
    Minerva Pediatr; 1991 Jun; 43(6):445-52. PubMed ID: 1886529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Electrophysiological and morphological effects of the injection of Guillain-Barré sera in the sciatic nerve of the rat (author's transl)].
    Sumner A; Said G; Idy I; Metral S
    Rev Neurol (Paris); 1982; 138(1):17-24. PubMed ID: 7100734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Electrophysiologic studies in Guillain-Barré syndrome].
    Norris Cummings B; González Sandoval C; Suárez Guglielmi H; Contreras Muñoz G; Concha Barahona J
    Bol Med Hosp Infant Mex; 1979; 36(4):529-40. PubMed ID: 465169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrophysiological changes in the acute "axonal" form of Guillain-Barre syndrome.
    Brown WF; Feasby TE; Hahn AF
    Muscle Nerve; 1993 Feb; 16(2):200-5. PubMed ID: 8429846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased electrical excitability of peripheral nerves in demyelinating polyneuropathies.
    Meulstee J; Darbas A; van Doorn PA; van Briemen L; van der Meché FG
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):398-400. PubMed ID: 9120460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
    Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
    Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hereditary sensorimotor neuropathy in electrophysiological studies].
    Emeryk-Szajewska B; Badurska B; Kostera-Pruszczyk A
    Neurol Neurochir Pol; 1998; 32(2):295-308. PubMed ID: 9760549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebrotendinous xanthomatosis: clinical, electrophysiological and nerve biopsy findings, and response to treatment with chenodeoxycholic acid.
    Donaghy M; King RH; McKeran RO; Schwartz MS; Thomas PK
    J Neurol; 1990 Jun; 237(3):216-9. PubMed ID: 2196342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nerve ischemia in Guillain-Barré syndrome: an alternative mechanism for early conduction failure.
    Berciano J; García A
    Rev Neurol (Paris); 2002 Mar; 158(3):364-5. PubMed ID: 11976600
    [No Abstract]   [Full Text] [Related]  

  • 59. Axonal form of Guillain-Barré syndrome: evidence for macrophage-associated demyelination.
    Berciano J; Coria F; Montón F; Calleja J; Figols J; LaFarga M
    Muscle Nerve; 1993 Jul; 16(7):744-51. PubMed ID: 8505931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent Guillain Barre' Syndrome: a clinical, electrophysiological and morphological study.
    Taly AB; Gupta SK; Anisya V; Shankar SK; Rao S; Das KB; Nagaraja D; Swamy HS
    J Assoc Physicians India; 1995 Apr; 43(4):249-52. PubMed ID: 8713263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.